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Abstract 	  
Aging occurs in almost all living organisms. As we grow old, we are at risk for 
many age-associated diseases like cardiovascular disease, diabetes, Huntington’s disease, 
and amyotrophic lateral sclerosis, to name a few. The underlying causes of these diseases 
are being heavily studied in the scientific community, in hopes that the diseases could be 
prevented or delayed. Studying the mechanisms and causes of chronic and 
neurodegenerative diseases could further result in various therapeutics to treat age-related 
diseases.  
 One approach to studying aging is the use of pharmacological agents and how 
they can extend lifespan and/or promote healthy aging. There are several reports that 
chemical compounds extend lifespan in various model organisms including 
Caenorhabditis elegans, Drosophila melanogaster, and Mus musculus. Pharmacological 
agents likely extend lifespan through activation of pro-longevity pathways and/or 
inhibition of pro-longevity pathways. Researchers have demonstrated that many 
mechanisms controlling aging are conserved, even across these diverse organisms. 
Therefore, pharmacological agents that target these pathways may eventually be able to 
improve human health.  
 To study aging using a pharmacological approach, I utilized the nematode 
Caenorhabditis elegans (C. elegans) as a model organism. I investigated a number of 
synthetic compounds and natural products in combination that are known to have a 
positive effect on the lifespan of C. elegans. Next, I examined the chemical compounds 
effects for improvements on the general health of the organism during the aging period 
(healthspan). Finally, I examined these compounds for any positive effect in a C. elegans 
	  	   vii	  
model of a human neurodegenerative disease. Overall, my results demonstrate that 
combinations of compounds extend lifespan and promote health aging in C. elegans.  
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Chapter 1 	  
Testing Chemical Compounds for 
Additive Effects on Longevity 
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1. Introduction 	  
	   Aging occurs in most life forms over time, and ultimately leads to the death of an 
organism. With aging, complex biological functions and pathways tend to decline and 
become imbalanced, leading to many chronic diseases. Aging is known to be associated 
with numerous neurodegenerative diseases such as Alzheimer’s disease (AD), 
Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease 
(HD) (Nussbaum-Krammer and Morimoto, 2014). The process and causes of aging are 
not fully understood. By understanding the mechanisms of such causes, scientists may be 
able to create interventions to delay the onset of these diseases. The impact of these 
findings could be the promotion of healthy aging and longevity. 
C. elegans as a model organism 	  
 The transparent nematode Caenorhabditis elegans (C. elegans) is a very useful 
model for aging studies. C. elegans share many biological structures and pathways with 
more complex organisms including humans, thus can be utilized as a model organism to 
study age-related disorders. Although we are distantly related, biological structures and 
processes such as cell signaling, metabolism, gene regulation, and specialized cells are 
shared between C. elegans and humans (Kaletta and Hengartner, 2006). C. elegans also 
has a short lifespan, an average of 21 days, and can be used in a variety of experimental 
approaches such as chemical compound treatment, environmental manipulations, and 
disease modeling (Olsen et al., 2006). The microscopic worm can be easily manipulated 
to produce mutant and transgenic strains by various methods, which has allowed 
scientists to study many biological processes and diseases. It is simple to study large 
numbers of age-synchronized populations as they are easily cultured and produce over 
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300 progeny via self-fertilization in five to seven days after hatching. These 
characteristics allow scientists to utilize C. elegans with far greater ‘through-put’ than 
other model organisms such as the lab mouse.  
Pharmacological studies of aging  	  
Studying various classes of compounds allows scientists to gain more knowledge 
about causes of aging by understanding a given compound’s mechanism of action. These 
classes include antioxidants, vitamins, laboratory made compounds, and anticonvulsants. 
Multiple chemical compounds have been shown to have an effect on aging in C. elegans. 
Previously reported studies show that antioxidants such as resveratrol (Wood et al., 2004) 
and disaccharides like trehalose (Honda et al., 2010) increase C. elegans lifespan. These 
group of compounds are known as natural products and have been shown to modulate 
lifespan in C. elegans and other organisms such as Drosophila melanogaster and mice 
(Spindler et al., 2013)  
Natural products are found in our environment and are produce by living 
organism such as plants. An example of a natural product is diallyl trisulfide. It has been 
shown to increase worm lifespan by enhancing the function of the pro-longevity 
transcription factor SKN-1 (Powolny et al., 2011). The transcription factor SKN-1 in C. 
elegans is orthologous to mammalian nuclear respiratory factor (Nrf) family of 
transcription factors. The Nrf family of transcription factors plays a critical role in 
mediating adaptive responses to cellular stress and defends against neurodegeneration 
and aging (Staab et al., 2013).  
 Additionally, natural products such as gossypolone, quercetin, and salicylic acid 
also have been shown to be beneficial. Gossypolone, the major metabolite of the 
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naturally-occurring compound gossypol, possesses anti-steroidogenic and anti-
reproductive activity (Gilbert et al., 1995). Gossypol has demonstrated anti-cancer 
activity and has been shown to have synergistic anti-tumor effects with valproic acid 
(Chen et al., 2016; Dong et al., 2016; Gong et al., 2015). Further investigation of both 
gossypol and gossypolone has been evaluated as a potential therapeutic for human breast 
cancer. Quercetin, a flavinol found in many fruits and vegetables, is being increasingly 
proposed as a nutraceutical for its healthful activities (Dueñas et al., 2013). Salicylic acid, 
a naturally-occurring compound found in plants, displays antioxidant activity (De La 
Cruz et al., 2004; Guerrero et al., 2004). In addition to those natural products, the salt 
ionic compound, Lithium chloride, is also known to be beneficial. It is currently used in 
the treatment for bipolar disorder (Vosahlikova and Svoboda, 2016) and has been shown 
to increase lifespan of C. elegans (McColl et al., 2008). Lithium chloride has even been 
correlated with longevity in humans (Zarse et al., 2011). 
Synthetic compounds, including FDA approved drugs, have also been tested for 
their effects on aging in C. elegans. Anticonvulsants have been observed to increase the 
lifespan of C. elegans (Collins et al., 2008; Evason et al., 2005; Kornfeld and Evason, 
2006). Anticonvulsants are a diverse group of pharmacological agents that modulate 
neural activity in vertebrates (Villalba et al., 2016). There is an extensive study of various 
synthetic compounds that has been shown in the Lithgow Laboratory to increase the 
lifespan of C. elegans. Alavez and colleagues found that the chemical compound 
thioflavin T (ThT), an amyloid-binding dye, extended the lifespan of C. elegans by 
improving protein homeostasis (Alavez et al., 2011). Another pro-longevity chemical 
compound identified in the Lithgow Laboratory is nitrophenyl piperazine-1 (NP1). NP1 
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was discovered by screening diverse drug like compounds for effectiveness at prolonging 
the lifespan of C. elegans. Lucanic and colleagues have shown that NP1 works through a 
dietary restriction (DR) mechanism (Lucanic et.al, in press at Aging Cell).  
Overview 
 With C. elegans as a model, I studied the additive effects of natural products and 
synthetic compounds on lifespan extension and healthspan promotion. I tested mixtures 
of natural products and a specific combination of synthetic compounds. I examined 
whether or not combinations of compounds could result in additive or synergistic effects 
on C. elegans lifespan extensions and whether these combinations of compounds could 
promote healthy aging. By understanding the effects of these compounds on lifespan and 
healthspan, we can further understand the role of aging and age-related diseases, with the 
goal of preventing age-related pathologies such as AD, HD, ALS, and PD. Additionally, 
identifying a vital mix of compounds can lead to novel therapeutics to treat age-
associated diseases. 
2. Materials and Methods 	  
2.1 C. elegans strains 
The wild-type (N2), TJ1060:spe-9(hc88);fer-15(b26) strains were obtained from 
the Caenorhabditis Genetics Center (CGC) (St. Paul, Minnesota).  
2.2 Synchronization of Worm Culture 
2.2.1 Standard Synchronization 
 Wild-type (N2) worms were synchronized via standard synchronization. The 
process began with 50 gravid adults placed in fresh nematode grown media (NGM) plates 
and were allowed to lay eggs for 1-2 hours. After the period of egg laying, the 50 gravid 
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adults were removed from the agar plate with a flattened platinum wire. The eggs left on 
the plates were placed back in the 20°C incubator and allowed to hatch. Three days later, 
the resulting synchronized population of day 1 adults was then used for aging 
experiments.  
2.2.2 Hypochlorite Synchronization 
TJ1060 animals were synchronized via hypochlorite synchronization. The animals 
were floated off the media of a plate with S-basal solution (a bacterial and nematode 
buffer). The liquid was then pulled off using a pipette and transferred to a 15mL conical 
tube. The tube was centrifuged at 1700 RPM for 1 min. and 30 sec., and the supernatant 
was aspirated. A hypochlorite solution (5mL KOH, 5mL NaOCl, and 40mL water) was 
added to the tube, and it was shaken and vortexed for approximately 5-7 minutes, or until 
the bodies of the adult worms were no longer visible. The tube was centrifuged again, 
and the hypochlorite solution was removed. The resulting eggs were washed with three 
washes of S-basal solution and centrifuged and aspirated each time. The eggs were placed 
in 50mL conical tubes containing fresh S-basal on a shaker for 48 hours yielding 
synchronous starved L1 larvae. After 48 hours, L1 larvae were spotted onto NGM plates 
and incubated at 25°C until experimental use at day 1 adulthood. 
2.3 Standard Media Preparation 
Unless otherwise stated, worms were cultured at 20°C on NGM plates. Standard 
NGM plates were made with Bacto™ agar, an algae-derived polysaccharide, Bacto™ 
peptone, a protein digest, and sodium chloride. NGM plate ingredients are as follows: 
17g of agar, 2.5g of peptone, 3g of NaCl, 975mL of water totaling a volume of 1L. In 
addition to those, 25ml of phosphate buffer (5M KPO4), 1mL of 1M MgSO4, 1mL of 1M 
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CaCl2, 1mL Cholesterol (5mg/mL) were added. Worm cultures were fed a strain of 
Escherichia coli called OP-50. 
2.4 FUdR Media 
For all lifespan assay plates, media with a chemical that inhibits DNA synthesis 
were prepared to prevent larval contamination. Media is prepared according to the 
standard preparation as mentioned above. In addition to the ingredients listed, 5-Fluoro-
1-[4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-pyrimidine-2,4-dione (FUdR) 
is added, resulting in a final concentration of 10µg/mL FUdR. 
2.5. Natural Product Screen 
 For the high-throughput screen, 96-well plates with all possible pair-wise 
combinations were tested in triplicate. One plate consisted of a master key of the 25 
natural products used and the other plates consisted of one single natural product. Using a 
multi-channel pipette, 0.3 µL was obtained from the master key plate and was pipetted in 
0.3 µL of the single natural product plate producing combination pairs. This was repeated 
until all natural products were mixed with one another. Approximately 10 gravid TJ1060 
animals were then placed in each well exposed to the pair-wise combinations. Plates were 
placed in 25°C until day 13. On day 13, plates were scored manually with a microscope. 
A percentage of live animals over total number of worms were obtained.  
2.6 Compound Treatments 
 Compounds tested were added to the NGM plates after addition of food (final 
concentration listed in parenthesis): diallyl trisulfide (5µM), gossypolone (22µM), 
lithium chloride (10mM), quercetin (100µM), salicylic acid (100µM), berberine chloride 
(100µM), vitamin A (50µM), myricetin (50, 100µM), curcumin (50, 100µM), NP1 (10, 
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50, 100, 200, 500µM), ThT (1, 10, 50, 100, 200µM). Compounds were dissolved into 
concentrated stock solutions and further diluted to working solutions prior to addition to 
assay plates. Compounds were always added at least one-day prior to use to allow for 
distribution of the chemicals throughout the cultured plates. Control vehicle was DMSO 
at a concentration of 0.25% unless otherwise stated.  
2.7 Lifespan Analysis 
Synchronized worm populations (from 1 hour egg lays) were added to 3cm NGM 
plates supplemented with 10µg/mL FUdR at day one of adulthood. All lifespan 
experiments were performed at 20°C unless otherwise stated. Worms were scored and 
transferred every other day, with weekly transfers to fresh NGM plates. 
Scoring/measuring was achieved by counting the worms on each plate and marking what 
was dead, alive, or lost/bag. Worms that failed to display touch-provoked movement 
were scored as dead. Worms that died from causes other an aging, such as sticking to the 
walls of the plates, internal hatching of eggs (‘bagging’), or gonadal extrusion were 
censored as lost/bag worms.  
Data from the lifespan experiments were entered in a binary fashion into Prism™ 
6.0 for Mac OS X (GraphPad Software, San Diego, California). Various tests were used 
within the Prism™ software to calculate statistical significance including log-rank 
(Mantel Cox) test and unpaired t-test. 
2.8 Healthspan Analysis 
2.8.1 Body Movement Measurement 
Age-related decrease in worm movement was analyzed as part of a healthspan 
measurement. Worms were recorded inside the bacterial lawn of either a 3cm NGM agar 
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plate or a 24-well, 2cm NGM plate. For experiments using the 3cm NGM plates, the 
Leica microscope (DFC 400, San Bernardino, CA) was used to capture 15-second digital 
video of a population of worms at 1.6x magnification and converted into audio video 
interleaved (AVI) file, a sound and motion picture format, prior to analysis using 
WormLab software (MBF Bioscience, Williston, Vermont). Each movie was analyzed 
using the average peristaltic speed of the worms. Peristaltic speed is defined as the 
forward movement of the worm (peristaltic track length) divided by seconds moving.  
For experiments using the 24-well NGM plates, the Zeiss microscope (Stemi 508, 
Pleasanton, CA) with a Canon Rebel (EOS Rebel T5i) attachment was used to capture 
15-second digital videos. The videos were at 1.6x magnification and converted into AVI 
file, prior to analysis using WormLab software. Each movie was analyzed using the 
average peristaltic speed metric. 
3. Results 
Natural product screen for pair-wise combinations effects on aging phenotype and  
longevity 	  
Single compounds have been shown to extend C. elegans lifespan but historically 
lack potency compared to genetic mutations. Genetic mutations in C. elegans are able to 
produce large lifespan effects, reports vary dramatically and examples include a robust 
doubling as well as an unusual 10-fold increase (Kenyon et al., 1993; Shmookler Reis et 
al., 2009). In addition, double mutations in C. elegans synergistically prolonged longevity 
by over 400% extension compared to control (Chen et al., 2013). However, single 
chemical compounds have exhibited relatively moderate effects on the lifespan of C. 
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elegans with between 20-30% considered strong and 40-60% relatively exceptional 
(Lucanic et al., 2013; Ye et al., 2014). 
To determine if combining chemicals in a pair-wise manner could mimic the 
lifespan effects of genetic mutations, a high-throughput screen was conducted using a list 
of natural products suspected or previously reported to extend lifespan. Compounds were 
tested in pairs with the intent of systematically finding additive and synergistic effects. 
Results from the screen identified a set of compounds that appeared to have positive 
lifespan effects on C.elegans. Noting the chemical structures, the products were not 
structurally related, with the exception of myricetin and quercetin (Fig. 1). These 
compounds were then used in standard lifespan assays for further evaluation, which 
would allow for the rational discovery of more complex mixtures. 
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Figure 1. Chemical structure of natural products. 
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Natural products effects on lifespan 	  
Many compounds have been shown to produce an effect on the lifespan of model 
model organisms including C. elegans. In the research community, attention has been 
focused on the protective role of naturally occurring antioxidants, generally in biological 
systems (Dkhil et al., 2015). Natural products are of interests because the Federal Drug 
Administration (FDA) generally recognizes many natural products such as vitamins, 
antioxidants, metabolites, and micronutrients as safe. With many beneficial effects of 
natural products, I chose to examine specific combinations to see if there may be additive 
benefits on the lifespan extension in C. elegans.  
 To determine whether or not combinations of compounds could cause positive 
effects on C. elegans lifespan, I generated a master mix of natural products and 
performed a lifespan experiment. These compounds were the top candidates from a high-
throughput screening of natural products for lifespan effects on C. elegans (Fig.1). 
Specifically, I studied the following cocktail mixture of natural products: diallyl trisulfide 
(5µM) +gossypolone (22µM) +lithium chloride (10mM) +quercetin (100µM) +salicylic 
acid (100µM). The mixture contained all five compounds at the concentration as 
mentioned. I performed the lifespan experiments at 25°C using TJ1060 animals, which 
are sterile when grown at this temperature. Assay was repeated at 20°C using wild-type 
(wt) N2 animals. Results from the lifespan at both 25°C and 20°C were similar in that the 
mixture of the five natural products did not produce any significant positive effects on the 
lifespan (Fig. 2 A and B). With the exception of lithium chloride, none of compounds 
individually increased lifespan.  
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Figure 2. C. elegans Survival Analysis with Various Treatments. A. Lifespan curve of 
synchronous population of genetic strain TJ1060 animals of C. elegans exposed to different compounds 
at 25°C. Control (n=45), dia tris (n=41), gossy (n=48), LiCl (n=36), quer (n=39), sal acid (n=42), mix 
(n=57) B. Lifespan curve of synchronous population of wild-type (N2) animals of C. elegans exposed 
to different compounds at 20°C. Control (n=109), dia tris (n=54), gossy (n=59), LiCl (n=55), quer 
(n=59), sal acid (n=58), mix (n=58). Statistical tests based on log-rank (Mantel-Cox) test. For more 
statistical analysis see table 1 and 2. 
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Table 1. Statistical Analysis of TJ1060 Survival  
Intervention Median n [censored] 
p-value (Mantel 
Cox) vs. control 
Ratio of median 
intervention vs. control 95% CI of ratio 
Control 9 45 [14]       
diallyl trisulfide 5µM 9 41 [16] 0.4256 1 0.6550 to 1.527 
gossypolone 22µM 9 48 [12] 0.7514 1 0.6658 to 1.502 
lithium chloride 10mM 12 36 [35] 0.0059/ ** 1.333 0.8602 to 2.067 
quercetin 100µM 10 39 [21] 0.1156 1.111 0.7237 to 1.706 
salicylic acid 100µM 8 42 [19] 0.8539 0.8889 0.5837 to 1.354 
Mix: dial tris +gossy 
+LiCl +quer +sal acid 10 57 [6] 0.763 1.111 0.7516 to 1.642 
 
 
Table 2. Statistical Analysis of N2 Survival  
Intervention Median n [censored] 
p-value (Mantel 
Cox) vs. control 
Ratio of median 
intervention vs. control 95% CI of ratio 
Control 11 109 [10]       
diallyl trisulfide 5µM 11 54 [6] 0.0896 1 0.7217 to 1.386 
gossypolone 22µM 11 59 [1] 0.9917 1 0.7285 to 1.373 
lithium chloride 10mM 12 55 [6] 0.0061/ ** 1.091 0.7889 to 1.509 
quercetin 100µM 11 59 [1] 0.4236 1 0.7285 to 1.373 
salicylic acid 100µM 11 58 [3] 0.547 1 0.7272 to 1.375 
Mix: dial tris +gossy 
+LiCl +quer +sal acid 11 58 [2] 0.0546 1 0.7272 to 1.375 
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Berberine chloride pair-wise combination affects lifespan 	  
 The fact that my initial approach of combining multiple compounds at once did 
not appear to extend lifespan, I began to find pair-wise combinations for testing. Using 
the results from the previously mentioned natural compound screen, I chose pair-wise 
combinations that were considered to produce additive lifespan extension in C. elegans. 
In the screen, berberine chloride, a naturally occurring plant alkaloid was among the top 
candidates with a positive effect on lifespan.  
Berberine chloride is well studied and known to have many biological effects 
such anti-inflammatory and anti-oxidative activities (Battu et al., 2010; Küpeli et al., 
2002; Misík et al., 1995). Berberine chloride combined with vitamin A, myricetin, 
gossypolone, or curcumin showed positive effects in the results from the screen, so I 
therefore performed thorough lifespan experiments with pair-wise combinations. Results 
for one experiment are shown in Fig. 3. In all of the combinations shown in Fig. 3 A-D, 
berberine chloride significantly increased lifespan compared to the control and the 
combinations acted similarly as berberine chloride itself. This suggests that there were no 
added benefit of the other natural products, since berberine chloride on its own could 
produce just as much of an extension. In all cases, the combination of compounds had the 
longest maximum lifespan compared to the individual compounds on their own and the 
control.  
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Figure 3. C. elegans Survival Analysis with Berberine Chloride Pair-wise Treatments. Lifespan 
curve of synchronous population of TJ1060 strain of C. elegans exposed to natural products at 25°C. A. 
brcl+vitA combination (p<0.0004, n=19). B. brcl+myr combination (p<0.0003, n=38). C. brcl+gosy 
combination (p<0.0073, n=40). D. brcl+curc combination (p<0.024, n=30). Statistical tests based on 
log-rank (Mantel-Cox) test. For more statistical analysis see table 3. 
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Combinatorial Mixture Increases Lifespan 	  
 From previous results, I found that berberine chloride on its own could produce a 
lifespan extension. In addition, a combination of berberine chloride and another natural 
compound could also produce a lifespan extension compared with control (Fig. 3). I then 
decided to revert back to my initial approach of combining more than two compounds to 
find a working cocktail mixture. I combined berberine chloride and three other 
compounds, vitamin A, curcumin, and myricetin, that have been shown to increase 
lifespan, in my own observation, data from the Lithgow Lab, and results from the screen, 
to see if I could find additive benefits.  
 Vitamin A, a nutritional organic compound, has been proven to be beneficial for 
the maintenance of the immune system and vision (Guo et al., 2012; Indrevær et al., 
2013; Maeda et al., 2009). Both curcumin, a natural phenol, and myricetin, a flavonoid 
compound, are known to have anti-inflammatory and antioxidant properties (Franceschi 
et al., 2016; Gokce et al., 2016; Latief et al., 2015). All of the compounds have also been 
shown to mediate lifespan extension in C. elegans. To determine whether this cocktail 
mixture could produce any positive lifespan effects, I performed a lifespan assay of the 
four compounds in combination and saw the following results shown in Fig. 4. The 
combinations of four compounds were able to produce significant extension compared to 
control. Two different concentrations of curcumin and myricetin were used because of 
the solubility issues that occurred. Nonetheless, both concentrations were able to produce 
significant lifespan extension when combined with the other two compounds. Berberine 
chloride alone also significantly increased the lifespan. These results were similar to the 
results shown in Fig. 3 A-D.  
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Figure 4. C. elegans Survival Analysis with Various Treatments. Lifespan curve of synchronous 
population of wild-type (N2) strain of C. elegans exposed to natural products at 20°C. A. Mix 1 
containing brcl (100µM), vitA (50µM), curc (100µM), and myr (100µM) significantly increased 
lifespan compared to control (p<0.0001, n=62). B. Mix 2 containing brcl (100µM), vitA (50µM), curc 
(50µM), and myr (50µM) significantly increased lifespan compared to control (p<0.0001, n=59.  
Statistical tests based on log-rank (Mantel-Cox) test. For more statistical analysis see table 4 and 5. 
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Table 4. Statistical Analysis of Mix 1 Survival 
Intervention Median n [censored] 
p-value (Mantel Cox) 
vs. control 
Ratio of median 
intervention vs. control 95% CI of ratio 
Control 15 93 [11]       
Mix 1: brcl +vitA +cur 
(100µM) +myr (100µM) 19 62 [6] < 0.0001/ **** 1.267 0.9185 to 1.747 
berberine chloride 22 54 [8] < 0.0001/ **** 1.467 1.049 to 2.051 
vitamin A 15 64 [6]  0.7613 1 0.7274 to 1.375 
curcumin 100 µM 19 62 [4] 0.0031/ ** 1.267 0.9185 to 1.747 
myricetin 100 µM 15 64 [5] 0.8221 1 0.7274 to 1.375 
 
 
Table 5. Statistical Analysis of Mix 2 Survival 
Intervention Median n [censored] 
p-value (Mantel Cox) 
vs. control 
Ratio of median 
intervention vs. control 95% CI of ratio 
Control 15 93 [11]       
Mix 2: 
brcl+vitA+cur(50µM)+m
yr(50µM) 22 59 [11] < 0.0001/ **** 1.467 1.057 to 2.036 
berberine chloride 
100µM 22 54 [8] < 0.0001/ **** 1.467 1.049 to 2.051 
vitamin A 50µM 15 64 [6]  0.7613 1 0.7274 to 1.375 
curcumin 50µM 19 69 [4] < 0.0001/ **** 1.267 0.9277 to 1.729 
myricetin 50µM 15 63 [4]  0.2498 1 0.7263 to 1.377 
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Nitrophenyl Piperazine-1 (NP1) and thioflavin T (ThT) in Combination Increases  
Lifespan 	  
In testing for more robust additive effects, I took another approach by looking at 
lifespan extension mediated by synthetic compounds. Prior to my arrival, there were two 
well studied chemical compounds in the Lithgow Laboratory that have been shown to 
produce significantly large lifespan extension. NP1 data has been reported to modulate 
the lifespan of C. elegans by Mark Lucanic. NP1 modulates sensory pathways that can 
elicit physiological responses associated with dietary restriction in C. elegans to extend 
their lifespan (Lucanic et.al., in press at Aging Cell). Sylvestre Alavez, a former post-
doctoral researcher in the Lithgow Lab, discovered that thioflavin T (ThT) had effects on 
lifespan in C. elegans (Alavez et al., 2011). ThT, an amyloid-binding dye, extended 
lifespan by improving protein homeostasis. 
To determine whether these two compounds could produce additive or synergistic 
effects on lifespan, I performed a lifespan experiment with both treatments administered 
simultaneously. I found that NP1 50µM and ThT 50µM additively increased lifespan 
compared to the control (Fig. 5). The median lifespan of the combination treated 
populations were greatly increased by 93% compared to the control animals. Critically, 
the combination also performed better than the individual compounds alone in terms of 
increasing lifespan.  
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Figure 5. NP1 and ThT Combined Produced Additive Lifespan Effects. A. NP1 chemical structure. 
B. ThT chemical structure. C. Lifespan curve of synchronous population of wild-type (N2) animals of 
C. elegans exposed to NP1 50µM, ThT 50µM, and NP1 50µM+ThT 50µM at 20°C from four 
technicians in four parallel experiments. All compounds extended lifespan compared to control. NP1 
and ThT together produced a significant effect in extension (p<0.0001, n=176). Statistical test based on 
log-rank (Mantel-Cox) test. For more statistical analysis see table 6. 	  	  
Table 6. Statistical Analysis NP1+ThT Survival 
Intervention Median n [censored] 
p-value (Mantel Cox) 
vs. control 
Ratio of median 
intervention vs. control 95% CI of ratio 
Control 15 245 [24]       
NP1 (50µM) 19 221 [24] < 0.0001/ **** 1.267 1.056 to 1.519 
ThT (50µM) 19 140 [133] < 0.0001/ **** 1.267 1.029 to 1.559 
NP1 (50µM) + ThT 
(50µM) 29 176 [67] < 0.0001/ **** 1.933 1.593 to 2.346 	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Optimizing NP1 and ThT Lifespan Effects on C. elegans 	  
NP1 and ThT repeatedly showed robust effects in producing a lifespan extension 
(Fig. 6). To determine the optimal dosage of NP1, I conducted a dose response assay 
using different concentrations of NP1. NP1 increased lifespan at various concentrations 
(Fig. 7). NP1 at 50µM demonstrated a 47% increase in median lifespan while NP1 at 
100µM indicated a 73% increase and 200µM indicated a 60% increase median lifespan 
compared to control. On the other hand, NP1 exhibited toxicity at a high concentration of 
500µM and significantly decreased lifespan of C. elegans.  
To determine the optimal dose of ThT, I also performed a ThT dose-dependent 
response assay similar to the NP1 dose-dependent assay. Results presented in Fig. 8 show 
that ThT increased lifespan at 10µM, 50µM, and 100µM. Results indicate that 10µM of 
ThT increased median lifespan by 47% compared to control (Fig. 8). ThT at 50µM and 
100µM both demonstrated a 13% increase in median lifespan compared to control. 
Similar to NP1 at 500µM, ThT at 200µM displayed extreme toxicity and significantly 
decreased lifespan. 
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Figure 6. Median Lifespan of Multiple Experiments Exposed to NP1, ThT, NP1+ThT 
Treatments. Median lifespan of individual lifespan experiments. Median lifespan was taken from 
survival analysis of synchronous population of wild-type (N2) exposed to NP1 (50µM), ThT 
(50µM), and NP1 (50µM)+ThT (50µM). Each dot represents an individual experiment consisting 
of an average of 65 worms. Standard error bars are shown. 	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Figure 7. C. elegans Survival Analysis with NP1 Treatment. Lifespan curve of synchronous 
population of wild-type (N2) animals of C. elegans exposed to 10µM of NP1 up to 500µM of NP1 at 
20°C. NP1 significantly extended lifespan at 10µM (p<0.0001, n=181), 50µM (p<0.0001, n=210), 
100µM (p<0.0001, n=228) and 200µM (p<0.0001, n=169). NP1 decreased lifespan at 500µM 
(p<0.0994, n=180). Statistical test based on log-rank (Mantel Cox) test. Graph represents three parallel 
experiments from three technicians. For more statistical analysis see table 7. 
 
 
Table 7. Statistical Analysis of NP1 Dose Response 
Intervention Median n [censored] 
p-value (Mantel Cox) 
vs. control 
Ratio of median 
intervention vs. control 95% CI of ratio 
Control 15 216 [12]       
NP1 10µM 15 181 [15] < 0.0001/ **** 1 0.8208 to 1.218 
NP1 50µM 22 210 [13] < 0.0001/ **** 1.467 1.213 to 1.773 
NP1 100µM 26 228 [10] < 0.0001/ **** 1.733 1.439 to 2.088 
NP1 200µM 24 169 [26] < 0.0001/ **** 1.6 1.308 to 1.957 
NP1 500µM 8 180 [43] 0.0994 0.5333 0.4376 to 0.6500 
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Figure 8. C. elegans Survival Analysis with ThT Treatment. Lifespan curve of synchronous 
population of wild-type (N2) animals of C. elegans exposed to 1µM of ThT up to 200µM of ThT at 
20°C. ThT extended lifespan at 10µM (p<0.0001, n=162), 50µM (p<0.0043, n=171), and 100µM 
(p<0.362, n=163). ThT significantly decreased lifespan at 200µM (p<0.0001, n=177). Statistical test 
based on log-rank (Mantel-Cox) test. Graph represents three parallel experiments from three 
technicians. For more statistical analysis see table 8. 	  
 
Table 8. Statistical Analysis of ThT Dose Response 
Intervention Median n [censored] 
p-value (Mantel Cox) 
vs. control 
Ratio of median 
intervention vs. control 95% CI of ratio 
Control 15 190 [18]       
ThT 1 µM 16 163 [47] 0.1391 1.067 0.8653 to 1.315 
ThT 10 µM 22 162 [50] < 0.0001/ **** 1.467 1.189 to 1.809 
ThT 50 µM 17 171 [38] 0.0043/ ** 1.133 0.9218 to 1.393 
ThT 100 µM 17 163 [32] 0.0362/ * 1.133 0.9193 to 1.397 
ThT 200 µM 3 177 [24] < 0.0001/ **** 0.2 0.1630 to 0.2454 
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NP1, ThT, and NP1+ThT Improves Movement 	  
There is no general definition of healthspan, in that it could mean a healthy period 
of time in a person’s life or a term used to predict age-related mortality (Crimmins, 
2015). In laboratory settings, particularly using C. elegans, we can broadly define 
healthspan by measuring physiological parameters over the lifespan of the worm (Bansal 
et al., 2015). One parameter that can be measured to study healthspan is the body 
movement of the worms. It has been published that age-related decline in movement of 
the worms is correlated with lifespan (Huang et al., 2004).  
Based on these findings, I examined the effects of NP1, ThT, and the 
combination, to see if these compounds would affect age-dependent decline in body 
movement of C. elegans. Results suggest that as worms age, their movement declines 
(Fig. 9). For the control animals, decline in movement plateaus from day 8 and beyond. 
With compound treatment, there is observable preservation of movement from day 9 to 
day 15, compared to controls (Fig. 9B). Animals with compound treatment performed 
better than control animals that were not on compound. The combination of NP1 and ThT 
did not exhibit additive or synergistic effects compared to the compounds alone. These 
results suggest that chemical compounds could delay the detrimental effects of movement 
in late-stage animals. 
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Figure 9. C. elegans Movement Analysis with NP1, ThT, and NP1+ThT Treatment. Peristaltic 
speed (forward movement/time) of wild-type (N2) animals was measured over the course of 19-23 
days. A. Average peristaltic speed of N2 animals on various compounds treatments. B. 
Quantitative analysis of day 9, day 10, day 12, and day 15. Error bars represent standard deviation. 
Statistical test based on unpaired t-test generated using Prism. For more statistical analysis see table 
9.	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Table 9. Statistical Analysis of C. elegans Movement  
 
	  
Day 9 
 
Day 10 
 
Day 12 
 
Day 15 
	  
Intervention n 
unpaired t test 
vs. control n  
unpaired t test 
vs. control n  
unpaired t test 
vs. control n  
unpaired t test 
vs. control 
Control 24   18   15   8   
NP1 50µM 15 0.0277/ * 13 0.0042/ ** 14 ns 15 0.003/ ** 
ThT 50µM 15 0.0172/ * 15] 0.005/ ** 12 0.0195/ * 15 0.0355/ * 
NP1 50µM+ 
ThT 50µM 15 0.0002/ ** 14  ns 14 0.0194/ * 13 0.0031/ ** 
 
4. Discussion 	  
Various chronic diseases increase in frequency with advancing age. These include 
an array of neurodegenerative diseases such as Parkinson’s disease (PD), Huntington’s 
disease (HD), and amyotrophic lateral sclerosis (ALS), and chronic diseases like 
cardiovascular disease, osteoporosis, and diabetes (López-Otín et al., 2013; Lucanic et 
al., 2013). In almost all cases, diseases accumulate from many factors such as disruption 
of protein balance, improper nutrition, genetic and environmental factors. The 
mechanism that links old age and diseases have yet to be fully determined but scientists 
have proposed many models. One method that holds promise for protecting against the 
harmful effects of aging is the use of novel compounds as potential treatments for age 
related diseases. My goal was to find novel combinations of compounds that could have 
potential effects in extending lifespan and further promote healthy aging, using a C. 
elegans model. 
Additive effects of chemical combinations 
 Chemical effects on aging are widely studied in various model organisms 
including C. elegans. In this thesis, I demonstrated that lifespan extension could be 
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achieved by combining chemical compounds. Whether they were synthetic or natural 
products, this procedure could generate an increase in lifespan. However, there were 
instances where a combination of the compounds, in a cocktail mixture or pair-wise 
manner, did not cause additive effects (Fig. 2 and 3). There could have been a variety of 
reasons why these mixtures did not increase lifespan or have any additive benefits. One 
reason is the solubility of the compounds when combined. Once combined some of the 
compounds appeared to come out of solution. Another reason may be due to the fact the 
natural products were not at its optimal dosages. A solution to the dosage problem is to 
perform dose-dependent assays with each natural product similar to the dose-dependent 
assays described here for NP1 and ThT (Fig. 7 and 8).  
Additionally, these compounds could be targeting the same pathway to increase 
lifespan, thereby perhaps precluding additive effects. On the other hand, the compounds 
could be activating pathways that have negative effects towards one another. For instance 
in Fig. 4, berberine chloride and curcumin alone, produced just as much of an extension 
as the mixture. Berberine chloride even produced a greater maximum lifespan compared 
to the mixture. The other compounds in Fig. 4, vitamin A and myricetin, had no effect on 
lifespan, therefore adding them to berberine chloride and curcumin in a mixture provided 
no further increase. More research needs to be conducted to further analyze the 
mechanism of actions.  
Optimizing compound dosage for robust effects on longevity 
In an attempt to optimize the correct dosage for the purpose of ensuring 
robustness of chemical compounds in C. elegans lifespan, NP1 and ThT dose-dependent 
assays were conducted (Fig. 7 and 8). From my observations of the various 
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concentrations of NP1, I found that 50µM of NP1 was the optimal dosage. This is mainly 
due to solubility issues with NP1 at 100µM and 200µM. At these doses, NP1 came out of 
solution when seeded on the NGM plates and precipitation from the chemical was visible, 
which was a confounding factor for the remainder of the experiment. However at 50µM 
of NP1, there was no observable precipitation and therefore was chosen as the optimal 
dosage for further experiments. This concentration is also consistent with previous data 
obtained from the Lithgow Laboratory. 
In the case of ThT, 10µM showed the most robust lifespan extension, in contrast 
to the previously published dose response where 50µM and 100µM had the most robust 
effect. This effect may be due to the fact that the authors’ started their lifespan at the 
fourth larval stage (L4) of the worms while I started my lifespans at day 1 of adulthood. 
In addition, I observed ThT increased the maximal lifespan by 21% at 50µM and 100µM 
compared with control. Although toxicity at the early ages of the worms is observable at 
50µM, I chose to use 50µM of ThT as my optimal dosage, which is consistent with the 
published paper. The cause of toxicity is yet to be determined.  
Healthy Aging 
 How long we live, and what proportion of that life is spent in healthy years, has 
important implication for individuals. These implications could range from potential 
burden of caregiving on surviving family members, valuing life-insurance, and adequacy 
of retirement benefits and savings (Beltrán-Sánchez et al., 2015). Improving healthspan 
and delaying or preventing age-related diseases would have huge benefits for society and 
on the individual level. The idea that chemical compounds that produced lifespan 
extension could promote healthy aging, steered me to test healthspan metrics.  
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 Here I have demonstrated that chemical compounds could improve healthspan in 
late-aged worms. Interventions that make animals live longer have the potential to make 
them healthier. These compounds’ combined mechanisms of action are not fully 
understood or have not been determined. One hypothesis for how lifespan extending 
compounds additively improve healthspan would be through accumulation of beneficial 
pathways that work jointly to produce such positive effects. In the case of NP1 and ThT, 
both compounds are known to be potent in different ways. NP1 is a compound, which 
elicits DR and thereby promotes lifespan extension. ThT’s mechanism of action is still 
unclear, but is believed to act through improved protein homeostasis for lifespan 
extension. Additional study and analysis needs to be conducted in order to define the 
molecular pathways of these compounds and to determine whether stimulation of these 
distinct pathways results in some emergent pathway effects not observed in either single 
treatment as suggest by the apparent synergistic effects we sometimes observed.  
 Another idea for determining the mechanism of action is to look at structure 
activity of the compounds (Fig. 1 and 5A and B). By examining the structures, we can 
identify more stable forms with better drug-like properties, perhaps improving efficacy 
and delivery. We can manipulate the structures such as removing or adding chemical 
groups and find the importance or differences between one structure and another and ask 
what happens to the activity. One example of chemical structures being closely related 
but produced opposite effects is the chemical compound BTA-1, a derivative of ThT. 
BTA-1 differs from ThT in that BTA-1 has three less methyl groups. In a preliminary 
experiment, I have determined that BTA-1 is very toxic in C. elegans even in the nM 
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range (data not shown), perhaps suggesting that methyl groups are of importance in 
stabilizing the structure for positive effects. 
5. Conclusion 	  
 Aging is a time-dependent functional decline that affects most organisms. By 
understanding how aging occurs and why various diseases are associated with aging, we 
can find ways to live a healthier life. Using C. elegans as model, I have demonstrated that 
chemical compounds in combination could extend its lifespan and further promote 
healthy aging. From such a small organism, research work in C. elegans can be translated 
into mice models furthering the potential for human clinical trials. The combinatorial 
approach will be key to finding the cocktail of compounds that might benefit mammalian 
healthspan.  
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Chapter 2 
Probing Effects of Compounds on 
       A Neurodegenerative C. elegans Model 
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1. Introduction 	  
Amyotrophic lateral sclerosis (ALS) is the most prominent adult-onset motor 
neuron disease (Witan et al., 2008). There are two types of ALS: sporadic and familial. 
Sporadic ALS is the most common form of the disease in the U.S. accounting for 90-95% 
of all cases while familial ALS (fALS) is an inherited disease and accounts for 5-10% of 
all cases (Boccitto et al., 2012). ALS is a complex disorder with a spectrum of 
phenotypes that could comprise a single disease or represent several closely related 
diseases. The clinical progression is generally rapid, beginning with muscle loss followed 
by muscle degradation, paralysis, and respiratory problems (Clerc et al., 2016). By 
understanding the mechanism behind this progression, we are better able to find therapies 
to treat ALS. 
Among some fALS cases, mutations in the copper (Cu)/ zinc (Zn)- superoxide 
dismutase-1 (SOD1) gene have been identified, but the general mechanism behind the 
genetic mutation of SOD1 causing such disease is debatable (Ogawa et al., 2015). A 
hallmark in SOD1-related disease is abnormal accumulation of misfolded proteins, 
further producing toxic protein aggregation build-up. SOD1 is a thermally stable enzyme 
that removes superoxide at the bound Cu ion and can be stabilized by binding of the Zn 
ion (Furukawa and O’Halloran, 2005).  
There is only one approved FDA drug, riluzole, which slows the progression 
ALS, but there are many symptomatic therapies (Salameh et al., 2015; Clerc et al., 2016). 
More research will have to be conducted to gain greater insight into human genes 
involved in ALS and understanding the disease phenotype at a molecular level. In chapter 
1 of this thesis, I surveyed many compounds that could increase lifespan and promote 
	  	   35	  
health aging in C. elegans. I next examined if these compounds could also be protective 
in an ALS phenotype. Specifically, I asked whether or not these compounds could 
interfere with the proteostasis network in relation to aging to increase lifespan and 
improve movement. 
C. elegans, whose genome contains homologs of approximately two-thirds of all 
human disease genes, are popular model organisms for studying human diseases (Olsen 
et al., 2006). To study ALS in C. elegans, I examined the transgenic mutant human SOD1 
overexpression model, G85R. C. elegans expressing human G85R SOD1 accumulate 
SOD1 aggregates and demonstrate reduced mobility (Boccitto et al., 2012). I studied the 
effects of compounds, which were known to extend lifespan, on the mobility of the ALS 
animals. Because Cu/Zn is important for stability of the SOD1 protein, I also examined 
the effects of Cu and Zn on improving the ALS phenotype. The significance of these 
findings will lead to future studies, translated to different model organisms such as the 
lab mice, for better understanding of ALS.  
2. Materials and Methods 	  
2.1 C. elegans strain 
The wild-type (N2) strain was obtained from the Caenorhabditis Genetics Center 
(CGC) (St. Paul, Minnesota). The transgenic C. elegans lines G85R (line 10) and wild-
type human SOD1 (line 7) were provided from the Wang lab, John Hopkins University 
(Baltimore, Maryland) (Wang et al., 2009). 
2.2 Synchronization of worm culture 
 See Chapter 1: Materials and Methods, 2.2 
2.3 Standard media prep 
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See Chapter 1: Materials and Methods, 2.3 
2.4 Compound treatment 
Compounds tested were added to the NGM plates after addition of food (final 
concentration listed in parenthesis): NP1 (50µM), ThT (50µM), trehalose (5mM), 
mianserin (50µM), ethylenediaminetetraacetic acid (EDTA) (2.8mM), ZnCl (1mM), 
CuCl (0.27mM). For further details see Chapter 1: Materials and Methods, 2.6. 
2.5 Healthspan Analysis: Thrashing/Body Bends Measurement 
Movement via body bends of N2, G85R, and SOD1 strains were measured as an 
alternative healthspan metric. Synchronous populations were transferred to chemical 
plates at day 1 of adulthood. After 24 hours, adult animals were transferred to 10µL S-
Basal buffer. After 30 seconds of adaptation to S-Basal, the number of body bends was 
then counted for 30 seconds. Movement of the worm from pharynx to tail defines a body 
bend. An average body bends of the worms from each compound and compound 
mixtures were plotted using Prism 6 software. Statistical tests such as an unpaired t-test 
was acquired via Prism 6 software. 
3. Results 
Temperature and FUdR effects on ALS phenotype 	  
 Before we began examining the effect of compounds on the ALS phenotype, I 
tested whether temperature had any effects on adult body bends. In addition to 
temperature, I also examined the worms on FUdR and non-FUdR. It has been shown that 
FUdR improved protein homeostasis, stress resistance, and healthspan in wild-type 
animals (Angeli et al., 2013). I examined the worms at 15°C, 20°C, and 25°C on non-
FUdR and FUdR-treated plates. Results in Fig. 1 show that at 15°C, worms on FUdR and 
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non-FUdR had no significant changes between the wild-type N2 (WTN2) and wild-type 
SOD1 (WTSOD1) compared with the mutant G85R. At 20°C, I observed that the mutant 
G85R moved a lot less than the two wild-type models and that there were no differences 
between FUdR and non-FUdR treatments. At 25°C, the mutant G85R had little 
movement which could mean that the worms development was severely affected at 25°C. 
Taken together these results, I moved forward in my experiments using FUdR conditions 
at 20°C since these conditions allowed me to cultivate worms for a longer period of time 
and there were no difference in movement between FUdR and non-FUdR treatments. 
Using FUdR-treated plates also allowed me to conduct experiments using synchronized 
populations without interference of hatchlings.  
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Figure 1. Temperature Effects on ALS Phenotype. Synchronous population of WTN2, 
WTSOD1, and G85R animals exposed to FUdR and non-FUdR conditions at day 1 of adulthood 
at temperatures of 15°C, 20°C. and 25°C. n=8 for each condition at all temperatures.  
 
 
Compound Treatments Improve Healthspan 	  
 In chapter 1, I identified compounds that had positive effects on lifespan and 
promoted healthy aging. Given these, I next wanted to examine whether compounds that 
have beneficial effects on lifespan could also improve movement (Fig. 2). G85R animals 
exhibited abnormal movement and in some cases paralysis. Using G85R mutants, I 
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examined whether the compounds had any effects on improving a movement phenotype. 
The compounds used are as follows: trehalose (5mM), ThT (50µM), NP1 (50µM), 
mianserin (50µM), and EDTA (2.8mM). Trehalose and ThT are both involved in having 
beneficial effects for protein misfolding disorders (Alavez et al., 2011; Mardones et al., 
2016). NP1 and mianserin, an anti-depressant, both have been reported to extend lifespan 
in C. elegans (Lucanic et al., 2013; Rangaraju et al., 2015). EDTA is a chelating agent 
that binds to metal ions such as iron and copper, forming stable complexes (Ibad et al., 
2016). The worms were treated with these compounds at day 1 and scored at day 2 and 
day 8. 
Results in Fig. 3 show that the mutant G85R phenotype could be rescued at a mid-
stage in life. At day 2, the G85R animals had poor performance in movement and we 
observed minimal to no rescue with the compounds. At day 8, the compounds ThT, 
mianserin, and EDTA rescued the effects in the G85R animals but it occurs at similar 
levels as WTN2 and WTSOD1. Collectively, this outcome potentially infer that there is 
an improvement in healthspan but it is probably is not specific to the ALS phenotype. 
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Figure 2. Chemical structures of compounds used for thrashing assay. Chemical compounds 
shown above refer to compounds used in thrashing assay except for NP1 and ThT. For chemical 
structures of NP1 and ThT, see chapter 1 Fig. 5. 
 
 
 
 
 
 
Figure 3. Body Bend Analysis of G85R Animals with Various Compound Treatments. 
Synchronous population of WTN2, WTSOD1, and G85R animals exposed to different 
compounds. n=8 for all conditions at day 2 and day 8. Error bars represent standard error.  
*= p ≤ 0.05, **= p ≤ 0.01. Statistical test based on unpaired t-test generated using Prism. 
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Additional Metal-binding Ions Improve Movement 
 
G85R animals are impaired metal-binding mutants which have largely reduced 
activity (Witan et al., 2008). Mutations in SOD1 can change the binding affinity for Cu 
and Zn. The fact that Cu/Zn is important for stabilizing SOD1, I examined whether or not 
changing the stoichiometry of zinc and copper ions could improve movement by 
preventing the misfolding of SOD1.  
By introducing zinc chloride (ZnCl) and copper chloride (CuCl), results show that 
the compounds could rescue the effects of movement. In Fig. 4, at day 2, CuCl elicited a 
slight rescue in movement on G85R animals but occurred below wild-type levels. On the 
other hand, ZnCl on day 2 did not significantly improve movement of G85R animals. On 
day 7, ZnCl and CuCl displayed significant increase in movement compared to the G85R 
control animals. These rescue also occurred below the levels of WTSOD1 animals. 
 
 
 
Figure 4. Body Bend Analysis of G85R Animals with ZnCl and CuCl Treatments. 
Synchronous population of WTN2, WTSOD1, and G85R animals exposed to ZnCl and CuCl. 
Thrashing was measured on day 2 and day7. n=8 for all conditions at day 2 and day 8. Error bars 
represent standard error. *= p ≤ 0.05, ***= p ≤ 0.001, ****= p ≤ 0.0001. Statistical test based on 
unpaired t-test generated using Prism. 
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4. Discussion  	  	   ALS is a progressive and fatal neurological disease that has no cure (Browne and 
Abbott, 2016). Pathogenic mechanisms that occur during this progression include but are 
not limited to mitochondrial dysfunction, inflammation, oxidative stress, and 
glutaminergic excitotoxicity (Cluskey and Ramsden, 2001; Zhu et al., 2015). While there 
is a variety molecular pathway associated with neuronal death in ALS, there is no clear 
primary driving force for the onset of ALS. Considering the high incidence of ALS and 
lack of viable therapies, more research should be conducted.  
In order to gain a better insight of ALS, I surveyed a variety of compounds in an 
attempt to decrease the effects of the observable movement phenotype. In this thesis, I 
have demonstrated that compound treatments could improve movement in animals 
expressing the ALS phenotype at a mid-late stage. However, this improvement may not 
be directly associated with ALS in general. One hypothesis to differentiate between 
observing the improvement to ALS-specific phenotype is to expose the wild-type strains 
to the compounds. This will allow us to study effects of the wild-type SOD1 mutants and 
N2 animals to G85R mutants. Likewise, perhaps the compounds that were chosen in this 
chapter were not at the correct dosage. A solution to this is to conduct dose-response 
assays similar to chapter 1 (Fig. 7 and 8).  
 Mutations in TARDBP, encoding TAR DNA-binding protein-43 (TDP-43), are 
also associated in ALS (Guo et al., 2011). ALS patients display presence of aggregated 
TDP-43 proteins. Mutant TDP-43 proteins expressed in C. elegans motor neurons are 
susceptible to misfolding, leading to protein insolubility and aggregation (Aggad et al., 
2014). The C. elegans model, TDP-43 proteinopathy, is an interesting model for further 
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research including the use of compounds that promote proteostasis. By using another 
model of ALS, we will be able to compare mutations associated with ALS.  
5. Conclusion 
 Neurodegenerative diseases are incurable and result from progressive 
deterioration and/or death of nerve cells. The underlying causes of neurodegenerative 
diseases remain a mystery due to the fact that there are many mechanisms involved in 
causing detrimental effects. Using a C. elegans ALS model, I have demonstrated that 
chemical compounds could promote improve movement in aged animals. This is a small 
step towards mechanistically finding how the compounds are able to interact with 
biological pathways to induce movement. Perhaps the approach of combinatorial 
compounds will be a strategic method that could provide a benefit in neurodegenerative 
disease models not only in C. elegans but also in Drosophila melanogaster and mice with 
hopes that the benefits will be translated to humans.  
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